Login / Signup

Effect of Daridorexant on the Pharmacokinetics of Midazolam, and on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Male Subjects.

Isabelle ZenklusenJasper DingemanseChristian RehMartine GéhinPriska Kaufmann
Published in: Drugs in R&D (2024)
This trial (NCT05480488) was registered on 29 July, 2022.
Keyphrases
  • atrial fibrillation
  • study protocol
  • phase iii
  • clinical trial
  • venous thromboembolism
  • direct oral anticoagulants
  • phase ii
  • randomized controlled trial
  • open label
  • placebo controlled